About Semler Scientific, Inc.
https://www.semlerscientific.comSemler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
CEO
Douglas Murphy-Chutorian
Compensation Summary
(Year 2024)
ETFs Holding This Stock
VTS.AX
Weight:0.00%
Shares:395.40K
STCE
Weight:2.95%
Shares:392.50K
XSU.TO
Weight:0.01%
Shares:320.97K
Summary
Showing Top 3 of 65
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
Grade Summary
Showing Top 4 of 4
Price Target
Institutional Ownership
INTERCHANGE CAPITAL PARTNERS, LLC
Shares:1.27M
Value:$27.1M
MORGAN STANLEY
Shares:1.23M
Value:$26.24M
BLACKROCK, INC.
Shares:860.64K
Value:$18.39M
Summary
Showing Top 3 of 142
About Semler Scientific, Inc.
https://www.semlerscientific.comSemler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $7.49M ▼ | $12.24M ▲ | $16.9M ▼ | 225.63% ▼ | $1.14 ▼ | $25.47M ▲ |
| Q2-2025 | $8.22M ▼ | $9.53M ▼ | $66.93M ▲ | 814.57% ▲ | $5.71 ▲ | $-1.94M ▲ |
| Q1-2025 | $8.84M ▼ | $39M ▲ | $-64.7M ▼ | -732.34% ▼ | $-6.74 ▼ | $-73.81M ▼ |
| Q4-2024 | $12.41M ▼ | $7.77M ▲ | $29.21M ▲ | 235.29% ▲ | $3.64 ▲ | $3.64M ▼ |
| Q3-2024 | $13.51M | $7.29M | $5.61M | 41.51% | $0.8 | $6.52M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $10.18M ▼ | $596.68M ▲ | $136.93M ▼ | $459.75M ▲ |
| Q2-2025 | $13.48M ▲ | $522.6M ▲ | $139.19M ▲ | $383.41M ▲ |
| Q1-2025 | $9.74M ▼ | $293.44M ▲ | $131.76M ▲ | $161.68M ▼ |
| Q4-2024 | $14.92M ▲ | $239.83M ▲ | $9.08M ▲ | $230.75M ▲ |
| Q3-2024 | $12.67M | $92.19M | $6.84M | $85.36M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $16.9M ▼ | $-32.95M ▼ | $-47.78M ▲ | $77.42M ▼ | $-3.31M ▼ | $-32.94M ▲ |
| Q2-2025 | $66.93M ▲ | $514K ▲ | $-149.67M ▼ | $152.9M ▲ | $3.75M ▲ | $-149.15M ▼ |
| Q1-2025 | $-64.7M ▼ | $-1.91M ▼ | $-87.31M ▲ | $90.14M ▼ | $919K ▼ | $-92.82M ▲ |
| Q4-2024 | $29.21M ▲ | $7.43M ▲ | $-121M ▼ | $115.82M ▲ | $2.25M ▲ | $-113.84M ▼ |
| Q3-2024 | $5.61M | $6.42M | $-8.44M | $1.25M | $-763K | $-2.01M |
CEO
Douglas Murphy-Chutorian
Compensation Summary
(Year 2024)
ETFs Holding This Stock
VTS.AX
Weight:0.00%
Shares:395.40K
STCE
Weight:2.95%
Shares:392.50K
XSU.TO
Weight:0.01%
Shares:320.97K
Summary
Showing Top 3 of 65
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
Grade Summary
Showing Top 4 of 4
Price Target
Institutional Ownership
INTERCHANGE CAPITAL PARTNERS, LLC
Shares:1.27M
Value:$27.1M
MORGAN STANLEY
Shares:1.23M
Value:$26.24M
BLACKROCK, INC.
Shares:860.64K
Value:$18.39M
Summary
Showing Top 3 of 142